Genomic & Biopharma News

Key hires during Q2 2019 at ORB
Deerfield Beach, July 19, 2019 - Ocean Ridge Biosciences (ORB) announces two key hires in Q2 2019.
ORB Company News, 2019-07-20 00:49:36

Higher antibiotic exposure linked to increased risk of Parkinson's disease
Higher exposure to commonly used oral antibiotics is linked to an increased risk of Parkinson's disease according to a recently published study by researchers form the Helsinki University Hospital, Finland.
News Medical Life Sciences, 2019-11-22 21:19:13

Dangerous bacteria send out warning signals when attacked by antibiotics
A bacterial infection is not just an unpleasant experience - it can also be a major health problem. Some bacteria develop resistance to otherwise effective treatment with antibiotics.
News Medical Life Sciences, 2019-11-22 21:13:29

Combination therapy improves survival in patients with hepatocellular carcinoma
Combination therapy with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab significantly improves overall survival and progression-free survival in patients with unresectable hepatocellular carcinoma compared to standard of care, showed results from a phase 3 study reported at the ESMO Asia 2019 Congress.
News Medical Life Sciences, 2019-11-22 20:49:32

ORB Employees Participate in 2019 Martin Luther King Day Event
ORB employees get a rare break from the lab on January 21, 2019. A group of Ocean Ridge Biosciences employees stepped out of the lab on a beautiful South Florida winter day to take part in an event honoring Martin Luther King. We got our hands dirty planting some flowers and shrubs at a local park in Deerfield Beach.
ORB Company News, 2019-01-22 23:24:59

Biosimilar for HER2+ breast cancer achieves similar overall response rate to reference drug
The trastuzumab biosimilar HLX02 achieved similar overall response rate to reference trastuzumab in women with human epidermal growth factor receptor 2-positive (HER2+) recurrent or previously untreated metastatic breast cancer, according to a large, randomized phase III study reported at the ESMO Asia 2019 Congress.
News Medical Life Sciences, 2019-11-22 20:41:03

Accelerating Medicines Partnership program for Parkinson’s disease launches new data portal
The Accelerating Medicines Partnership program for Parkinson's disease (PD) has launched a data portal to provide de-identified information collected from 4,298 PD patients and healthy controls to researchers working to develop effective therapies for the disease.
News Medical Life Sciences, 2019-11-22 20:35:40

Financial Aid Recipients Breaking Funding Rules: Investigation
Many early-career clinical scientists receiving support through the NIH’s Loan Repayment Program have accepted disallowed industry funding, Science reveals.
The Scientist, 2019-11-22 20:30:32

Decreasing inappropriate antibiotic use is key strategy to control drug resistance
Antibiotic resistance is a larger public health threat than most people realize. And, the Centers for Disease Control and Prevention reports about half of all antibiotics in outpatient settings are incorrectly prescribed.
News Medical Life Sciences, 2019-11-22 20:20:30

Accelerating Medicines Partnership launches data knowledge portal for Parkinson’s disease
Shared platform to catalyze research collaboration toward biomarker discovery to advance the development disease therapies.
National Institutes of Health, 2019-11-22 20:15:00

How the digital age impacts longevity and lifestyle?
Have you ever wondered how does the digital age affect our longevity? What effect new technologies and knowledge advances have on our life?
News Medical Life Sciences, 2019-11-22 20:14:00